# Study of a New Medical Device in Gel Formulation Versus Calgel® for the Topical Treatment of Teething in Infants

> **NCT02931357** · PHASE3 · COMPLETED · sponsor: **Ricerfarma S.r.l** · enrollment: 54 (actual)

## Conditions studied

- Pain Teeth

## Interventions

- **DEVICE:** Hyaluronic Acid 0.54%
- **DRUG:** Calgel®

## Key facts

- **NCT ID:** NCT02931357
- **Lead sponsor:** Ricerfarma S.r.l
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2013-09
- **Final completion:** 2013-12
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2019-10-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02931357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02931357, "Study of a New Medical Device in Gel Formulation Versus Calgel® for the Topical Treatment of Teething in Infants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02931357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*